Professional Documents
Culture Documents
3 High Risk Pregnancy
3 High Risk Pregnancy
Assessment of
High Risk Pregnancy
(Prenatal)
Rhealeen V. Vicedo, MAN, RN
PRENATAL DIAGNOSIS
• Using a wide variety of screening and
diagnostic tests to assess health of a fetus to:
• Manage the pregnancy
• Determine potential outcomes
• Plan for complications at birth
• Decide whether to continue the pregnancy
• Discover conditions that may impact future
pregnancies
HIGH RISK PREGNANCY
• The condition wherein the maternal and
fetal life is jeopardized by a disorder
coincidental or unique to pregnancy.
RISK FACTORS
• Any finding that suggest the pregnancy may
have a negative outcome, for either the woman
or her unborn child
• Can be identified during the initial assessment;
others may be detected during subsequent
prenatal visits.
What is screening?
• a process of identifying apparently healthy
people who may be at increased risk of a
disease or condition.
• They can then be offered information, further
tests and appropriate treatment to reduce their
risk and/or any complications arising from the
disease or condition.
What is assessment?
• a process for:
o defining the nature of the problem
o determining a diagnosis, and
o developing specific treatment
recommendations.
CATEGORIES OF
(Assessment Tool)
1. MATERNAL AGE AND PARITY
FACTORS
a. H - high parity (5 or more)
b. I - interval of 8 years or more since last
pregnancy /pregnancy after 3 months or
less after the last delivery
c. M - multipara 40 or over
d. A - age 16 and below
e. N - nullipara 35 and above
2. Maternal diseases
• 2.1. Pregnancy Induced Hypertension (PIH)
a. P - pre-eclampsia with hospitalization
before
b. E - eclampsia
c. C - chronic hypertension
(160/100 mmHg and over)
a. K - kidney disease (pyelonephritis, end
stage kidney disease)
2. Maternal diseases
2.2. Anemia
• Physiologic
• Pathologic
2. Maternal diseases
2.3. Hemorrhage
• History of previous hemorrhage
• Risks:
– fetal loss - < 0.5% higher than normally
expected
– trauma and infection,
– risk of club foot reported when done < 13
weeks
• Later in pregnancy (eg. third trimester),
amniotic fluid can be taken to assess fetal
lung maturity prior to a premature delivery
Chorionic Villus Sampling
• Invasive technique to obtain fetal cells
• Study chromosomes, DNA, or biochemical profile of
fetus
• Most often approached through the vagina but may
be approached through the abdomen of mother
• Most often performed between 10-13 weeks
gestation, but as early as 9 weeks and any time after
13 weeks
• More genetic material from cells to study right away
Chorionic Villus Sampling
• Risks:
– fetal loss rate slightly higher than amnio -
about 1%
– Very slight risk of increased limb
abnormalities if done < 10 weeks
– risk of infection
Percutaneous Umbilical
Blood sampling
• Mild------------ 8 – 10 mg %
• The fetus requires a total of about 350 to 400 mg of iron per day
to grow.
● Prematurity
● Stillbirth
● Neonatal death
● Severe IDA
MANAGEMENT OF IRON
DEFICIENCY ANEMIA
● Total iron requirement 700-1400mg, 4mg/day
● WHO recommends: 30-60mg/day ≈ 1tab Obimin/ 1tab
Ferrous Fumerate (for women with normal iron level)
● Hb levels increase 0.3mg/week
● At least 180 mg /day of elemental iron required for
therapeutic management
● Hb levels need to be checked 2 weeks after commencing
treatment
FOLATE DEFICIENCY
ANEMIA
• Folic acid is needed in higher doses
• increased cell replication , taking place in fetus ,
uterus and bone marrow.
• 800 ug is required / day , but pre existing
deficiency is common mainly due to inadequate
diet / intestinal malabsorption syndrome .
FOLATE DEFICIENCY
ANEMIA
• More common in:
• twin pregnancy
• multigravida ,
• hook worm infestation ,
• GIT diseases , bleeding piles
• Haemolytic conditions ,
• malaria and other infections
● IUGR